ATC Pharma

Liège 4000

0 studies enrolling now · 1 studies all time

What they study most

Extraintestinal Pathogenic Escherichia Coli Prevention

Studies at this site

• A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health — Completed